Orgentec specializes in diagnostic assays that are used by laboratories in more than 100 countries. The company develops and produces tests, primarily enzyme-linked immunosorbent assays (ELISA), that help diagnose the increasing number of people impacted by autoimmune disorders and infectious diseases. It is one of the only companies in its field to offer a proprietary automated instrument – the Alegria – and associated test kits that enable labs to complete multiple assays and deliver faster results than traditional tests. Headquartered in Germany, Orgentec has a strong position in Europe and a growing presence in Asia, Latin America and the Middle East. Water Street invested in Orgentec in 2014 and helped the company acquire Corgenix in 2015 to establish a strong foothold in the United States. We are continuing to work with the leadership team to expand Orgentec into new areas of testing and geographic markets.
Chief Executive OfficerWork with us
Werner Hofacher has more than 30 years of experience leading global diagnostic and life sciences companies. Water Street recruited him to spearhead Orgentec’s strategic expansion in 2014. Prior to Orgentec, Werner achieved a highly regarded career at Beckman Coulter. He served in a number of executive positions for the company before being promoted to lead all of its European operations. During his tenure at Beckman, Werner was instrumental in facilitating the company’s successful integration into Danaher Corporation. Werner’s experience also includes leadership positions at Baxter Deutschland GmbH and Dade Diagnostica GmbH.